LTIMindtree reported broad-based growth in its second quarter, driven by a combination of digital transformation wins and AI-focused initiatives. The company’s consolidated revenue in USD reached ₹10,394 crore, up 5.6% quarter-on-quarter (QoQ) and 10.2% year-on-year (YoY).
Net profit rose 6.6% sequentially to ₹1,568 crore.
CEO Venu Lambu highlighted the company’s AI ambitions, saying, “We are committed to becoming an AI-centric organisation, leveraging our BlueVerse ecosystem. Our strategy remains on course, and our results reflect disciplined execution, the depth of our client relationships, and solid progress in our ongoing transformation.”
Announced in June, BlueVerse is a new business unit offering a comprehensive suite of AI-driven services designed to help companies adopt and scale AI across operations. It includes over 300 specialised AI agents across industries and functions, all built to work seamlessly within existing systems.
LTIMindtree added 2,558 employees in the quarter, taking its workforce to 86,447, with utilisation at 88.1% and trailing 12-month attrition at 14.2%.
The company secured several high-profile deals this quarter, including a large engagement with a global media and entertainment company to drive an AI-centric digital transformation, and a multi-geography partnership with a financial institution as one of its five major service partners.
LTIMindtree will deploy its BlueVerse technology for AI-driven efficiencies and innovation in sectors ranging from chemicals to hospitality, fintech, and government projects, including India’s PAN infrastructure transformation.
Most recently, LTIMindtree, along with Infosys, Cognizant, and Accenture, pledged a combined investment exceeding $1.5 billion to accelerate adoption and development on Oracle’s newly launched AI Data Platform. The funding will support large-scale training programs, R&D, and the creation of over 100 industry-specific AI use cases across sectors, including manufacturing, utilities, financial services, and healthcare.
Your reaction
Discussion
What's your take on this story?
No comments yet — be the first to share your view.